All In MedTech

Device Trial Radar · NCT01032902

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

Study to Establish the Ability of the Chembio Diagnostics Systems, Inc. DPP HIV 1/2 Rapid Test to Qualitatively Detect the Presence of Antibodies Against HIV-1 in Oral Fluid, Whole Blood (Capillary and Venous), Serum and Plasma

Last checked: Nov 20, 2026Latest source record: Apr 30, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

2,808

Actual

Start

Jan 2010

Primary completion

Apr 2012

Study completion Apr 2012

Sponsor

Lead sponsor
Chembio Diagnostic Systems, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 16, 2009

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 2 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of antibodies against HIV-1/2 in oral fluid, whole blood (capillary and venous), serum or plasma. This study will assess the DPP® HIV 1/2 Screen assay's ability to detect HIV-1.

Conditions

  • HIV Infections

Interventions

  • In Vitro Diagnostic DeviceDevice

    For the detection of antibodies to HIV in serum, plasma, blood and oral fluid

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The device detects HIV-1 antibodies in a variety of sample matrices: capillary whole blood, venous whole blood (with EDTA or heparin anticoagulant), oral fluid, serum and plasma (with EDTA or heparin anticoagulant).Time frame: 20 minutes

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Univeristy of California, San Diego

    La Jolla, California

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.